Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (guide4DBS-PD)

Movement Disorders

Volumn 25, Issue 11, 2010, Pages 1530-1537

  Vitek, Jerrold Lee ^a   Lyons, Kelly E ^b   Bakay, Roy ^c   Benabid, Alim Louis ^d   Deuschl, Guenther ^e   Hallett, Mark ^f   Kurlan, Roger ^g   Pancrazio, Joseph J ^f   Rezai, Ali ^h   Walter, Benjamin L ⁱ   Lang, Anthony E ^j  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIV GRENOBLE ALPES   (France)

^e UNIVERSITY OF KIEL   (Germany)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^g OVERLOOK HOSPITAL   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^j UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Deep brain stimulation; Movement disorders; Parkinson's disease; Publication guidelines

Indexed keywords

ANESTHETIC AGENT; ANTIPARKINSON AGENT; LEVODOPA;

BRAIN DEPTH STIMULATION; GENERAL ANESTHESIA; HUMAN; MEDICAL DOCUMENTATION; MENTAL DISEASE; NEUROLOGIC DISEASE; PARKINSON DISEASE; PATIENT ASSESSMENT; PATIENT SELECTION; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PEROPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

DEEP BRAIN STIMULATION; GUIDELINES AS TOPIC; HUMANS; PARKINSON DISEASE; PUBLICATIONS;

EID: 77955817630     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23151     Document Type: Review

References (54)

1. Pahwa R, Factor SA, Lyons KE, et al. Practice parameter: treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): report of the Quality Standards Sub-committee of the American Academy of Neurology. Neurology 2006;66:983-995.
2. Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 2005;20:523-539.
3. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-S304.
4. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
5. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
6. Zesiewicz TA, Elble R, Louis ED, et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005;64:2008-2020.
7. Lyons KE, Pahwa R. Deep brain stimulation and tremor. Neurotherapeutics 2008;5:331-338.
8. Mueller J, Skogseid IM, Benecke R, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial. Mov Disord 2008;23:131-134.
9. Loher TJ, Capelle HH, Kaelin-Lang A, et al. Deep brain stimulation for dystonia: outcome at long-term follow-up. J Neurol 2008;255:881-884.
10. Ostrem JL, Starr PA. Treatment of dystonia with deep brain stimulation. Neurotherapeutics 2008;5:320-330.
11. Kupsch A, Benecke R, Muller J, et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006;355:1978-1990.
12. Mink JW, Walkup J, Frey KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006;21:1831-1838.
13. Ackermans L, Temel Y, Visser-Vandewalle V. Deep brain stimulation in Tourette's syndrome. Neurotherapeutics 2008;5:339-344.
14. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45: 651-660.
15. Malone DA, Jr, Dougherty DD, Rezai AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009;65:267-275.
16. Greenberg BD, Gabriels LA, Malone DA, Jr, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience. Mol Psychiatry 2010;15:64-79.
17. Kuhn J, Lenartz D, Huff W, et al. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry 2007;78:1152-1153.
18. Franzini A, Cordella R, Nazzi V, Broggi G. Long-term chronic stimulation of internal capsule in poststroke pain and spasticity. Case report, long-term results and review of the literature. Stereotact Funct Neurosurg 2008;86:179-183.
19. Bartsch T, Pinsker MO, Rasche D, et al. Hypothalamic deep brain stimulation for cluster headache: experience from a new multicase series. Cephalalgia 2008;28:285-295.
20. Leone M, Franzini A, Felisati G, et al. Deep brain stimulation and cluster headache. Neurol Sci 2005;26(Suppl 2):s138-s139. (Pubitemid 40796499)
21. Schiff ND, Giacino JT, Kalmar K, et al. Behavioral improvements with thalamic stimulation after severe traumatic brain injury. Nature 2007;448:600-603.
22. Altman DG, Schulz KF, Moher D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663-694. (Pubitemid 32322245)
23. Bossuyt PM, Reitsma JB, Bruns DE, et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-W12.
24. Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004;94:361-366.
25. Chang S, Vogelbaum M, Lang FF, et al. GNOSIS: guidelines for neuro-oncology: standards for investigational studies - reporting of surgically based therapeutic clinical trials. J Neurooncol 2007; 82:211-220.
26. Chang SM, Reynolds SL, Butowski N, et al. GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neurooncology 2005; 7:425-434.
27. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
28. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934. (Pubitemid 37409709)
29. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
30. Lang AE, Houeto JL, Krack P, et al. Deep brain stimulation: preoperative issues. Mov Disord 2006;21(Suppl 14):S171-S196.
31. Deuschl G, Herzog J, Kleiner-Fisman G, et al. Deep brain stimulation: postoperative issues. Mov Disord 2006;21(Suppl 14): S219-S237. (Pubitemid 44028283)
32. Fahn S, Elton RL.Members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A, editors. Recent developments in Parkinson's disease. Florham Park, New Jersey: Macmillan Health Care Information; 1987. p 153-163.
33. Goetz CG, Nutt JG, Stebbins GT, Chmura TA. Teaching program for the Unified Dyskinesia Rating Scale. Mov Disord 2009; 24:1296-1298.
34. Goetz CG, Nutt JG, Stebbins GT. The Unified Dyskinesia Rating Scale: presentation and clinimetric profile. Mov Disord 2008; 23:2398-2403.
35. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol 1998;245(Suppl 1):S10-S14.
36. Hauser RA, Deckers F, Lehert P. Parkinson's disease home diary: further validation and implications for clinical trials. Mov Disord 2004;19:1409-1413.
37. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study. Lancet Neurol 2008;7:605-614.
38. Voon V, Kubu C, Krack P, Houeto JL, Troster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006;21(Suppl 14):S305-S327.
39. Mason LJ, Cojocaru TT, Cole DJ. Surgical intervention and anesthetic management of the patient with Parkinson's disease. Int Anesthesiol Clin 1996;34:133-150.
40. Maltete D, Navarro S, Welter ML, et al. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol 2004;61:390-392.
41. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628.
42. Paulsen KD, Miga MI, Kennedy FE, Hoopes PJ, Hartov A, Roberts DW. A computational model for tracking subsurface tissue deformation during stereotactic neurosurgery. IEEE Trans Biomed Eng 1999;46:213-225.
43. Bourgeois G, Magnin M, Morel A, et al. Accuracy of MRI-guided stereotactic thalamic functional neurosurgery. Neuroradiology 1999;41:636-645.
44. Walton L, Hampshire A, Forster DM, Kemeny AA. A phantom study to assess the accuracy of stereotactic localization, using T1-weighted magnetic resonance imaging with the Lek-sell stereotactic system. Neurosurgery 1996;38:170-176; discussion 6-8.
45. Maciunas RJ, Galloway RL, Jr, Latimer JW. The application accuracy of stereotactic frames. Neurosurgery 1994;35:682-694; discussion 94-95.
46. Alterman R, Reiter G, Shils J, et al. Targeting for thalamic deep brain stimulator implantation without computer guidance: assessment of targeting accuracy. Stereotact Funct Neurosurg 1999; 72:150-153.
47. Duffner F, Schiffbauer H, Breit S, Friese S, Freudenstein D. Relevance of image fusion for target point determination in functional neurosurgery. Acta Neurochir 2002;144:445-451.
48. Benabid AL, Koudsie A, Benazzouz A, et al. Subthalamic stimulation for Parkinson's disease. Arch Med Res 2000; 31:282-289.
49. Cuny E, Guehl D, Burbaud P, Gross C, Dousset V, Rougier A. Lack of agreement between direct magnetic resonance imaging and statistical determination of a subthalamic target: the role of electrophysiological guidance. J Neurosurg 2002;97:591-597.
50. Zonenshayn M, Rezai A, Mogilner A, Beric A, Sterio D, Kelly P. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000;47: 282-292.
51. Villemure JG, Marchand E, Peters T, Leroux G, Olivier A. Magnetic resonance imaging stereotaxy: recognition and utilization of the commissures. Appl Neurophysiol 1987;50:57-62.
52. Schuurman P, de Bie R, Majoie C, Speelman J, Bosch D. A prospective comparison between three-dimensional magnetic resonance imaging and ventriculography for target-coordinate determination in frame-based functional stereotactic neurosurgery. J Neurosurg 1999;91:911-914.
53. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357: 1191-1194. (Pubitemid 32378696)
54. Videnovic A, Metman LV. Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord 2008;23:343-349.